A lyophilized etoposide submicron emulsion with a high drug loading for intravenous injection: preparation, evaluation, and pharmacokinetics in rats

References

• Hande KR. (1998). Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer, 34:1514–21.
   PubMed Web of Science ®Google Scholar
• Issell BF, Crooke S. (1979). Etoposide (VP-16-213). Cancer Treat Rev, 6:107–24.
   PubMed Web of Science ®Google Scholar
• Clark PI, Slevin ML. (1987). The clinical pharmacology of etoposide and teniposide. Clin Pharmacokinet, 12:223–52.
   PubMed Web of Science ®Google Scholar
• O'Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE. (1985). Etoposide (VP-16-213). Current status of an active anticancer drug. N Engl J Med, 312:692–700.
   PubMed Web of Science ®Google Scholar
• Smit EF, Carney DN, Hurford P, Sleijfer DT, Postmos PE. (1989). Phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax, 44:257–63.
   Google Scholar
• Beijnen JH, Holthuis JJM, Kerkdijk HG, van der Houwen OAGJ, Paalman ACA, Bult A, . (1988). Degradation kinetics of etoposide in aqueous solution. Ind J Pharm Sci, 41:169–78.
   Web of Science ®Google Scholar
• Shah JC, Chen JR, Chow D. (1989). Preformulation study of etoposide: Identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res, 6:408–12.
   PubMed Web of Science ®Google Scholar
• Hande KR. (1992). Etoposide pharmacology. Semin Oncol, 19(Suppl. 13):3–9.
   PubMed Web of Science ®Google Scholar
• O'Dwyer PJ, Weiss RB. (1984). Hypersensitivity reactions induced by etoposide. Cancer Treat Rep, 68:959–61.
   PubMedGoogle Scholar
• Suttmann H, Doenicke A, Kugler J, Laub M. (1989). A new formulation of etomidate in lipid emulsion–bioavailability and venous provocation. Anaesthesist, 38:421–3.
   PubMed Web of Science ®Google Scholar
• Wang J, Cui Y, Tang X. (2009). Chemical stability of teniposide in aqueous and parenteral lipid emulsions. Drug Dev Ind Pharm, 35:508–13.
   PubMed Web of Science ®Google Scholar
• Cox JW, Sage PG, Wynalda MA, Ulrich RG, Larson PG, Su CC. (1991). Plasma compability of injectables: Comparsion of intravenous U-74006, a 21-aminosteroid antioxidant, with Dilantin brand of parenteral phenytion. J Pharm Sci, 80:371–5.
   PubMed Web of Science ®Google Scholar
• Gao K, Sun J, Liu K, Liu X, He Z. (2008). Preparation and characterization of a submicron lipid emulsion of docetaxel: Submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm, 34:1227–37.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mesfin GM, Rodriguez CA, Slatter JG, Schuette MR, Cory AL, . (1999). Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion. Pharm Res, 16:930–8.
   PubMed Web of Science ®Google Scholar
• Jang JH, Kim CK, Choi HG, Sung JH. (2009). Preparation and evaluation of 2-(allylthio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting. Drug Dev Ind Pharm, 35:363–8.
   PubMed Web of Science ®Google Scholar
• Shi S, Chen H, Cui Y, Tang X. (2009). Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion. Int J Pharm, 373:147–55.
   PubMed Web of Science ®Google Scholar
• Tian L, He H, Tang X. (2007). Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion. J Pharm Sci, 96:1719–28.
   PubMed Web of Science ®Google Scholar
• Patlolla RR, Vobalaboina V. (2004). Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci, 94:437–45.
   Web of Science ®Google Scholar
• Lovell MW, Johnson HW, Hui HW, Gupta PK, Hsu CC. (1994). Less painful emulsion formulations for intravenous administration of clarithromycin. Int J Pharm, 109:45–57.
   Web of Science ®Google Scholar
• Li F, Wang T, He HB, Tang X. (2008). The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization. Int J Pharm, 349:291–9.
   PubMed Web of Science ®Google Scholar
• Gabetta B, Bombardelli E, Pifferi G. (1987). Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions. Europe patent no. 209038, 1987–01–21.
   Google Scholar
• Jianmei W, Dawei CH, Yanli L. (2001). Study on the preparation of baicalin complex with phospholipids. Chin J Chin Mater Med, 26:166–9.
   Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. (2007). Curcumin–phospholipid complex: Preparation, therapeutic, evaluation and pharmacokinetic study in rats. Int J Pharm, 330:155–63.
   PubMed Web of Science ®Google Scholar
• Yanyu X, Yunmei S, Zhipeng C, Qineng P. (2006). The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 307:77–82.
   PubMed Web of Science ®Google Scholar
• Han J, Washington C, Davis SS. (2007). Design and evaluation of an emulsion vehicle for paclitaxel. II. Suppression of the crystallization of paclitaxel by freeze-drying technique. Drug Dev Ind Pharm, 33:1151–7.
   PubMed Web of Science ®Google Scholar
• Miyajima K. (1997). Role of saccharides for the freeze-thawing and freezedrying of liposome. Adv Drug Deliv Rev, 24:151–9.
   Web of Science ®Google Scholar
• Ausborn M, Schreier H, Brezesinski G, Fabian H, Meyer HW, Nuhn P. (1994). The protective effect of free and membrane-bound cryoprotectants during freezing and freeze-drying of liposomes. J. Control Release, 30:105–16.
   Web of Science ®Google Scholar
• Crowe JH, Leslie SB, Crowe LM. (1994). Is vitrification sufficient to preserve liposomes during freeze-drying? Cryobiolog, 31:355–66.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. (1997). Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm, 157:171–9.
   PubMed Web of Science ®Google Scholar
• Müller RH, Heinemann S, Diederichs JE. (1991). Parenteral fat emulsions II: Charge and rigidity of emulsifier film related to long-term stability. Proc Intern Symp Control Relat Bioact Mater, 18:469.
   Google Scholar